InvestorsHub Logo
Followers 3420
Posts 32269
Boards Moderated 1
Alias Born 07/08/2006

Re: $heff post# 54539

Thursday, 05/24/2012 10:18:11 AM

Thursday, May 24, 2012 10:18:11 AM

Post# of 97239
ONXX..$45.40 up over 3% or $1.51. Nice move after disappointing lung cancer trials.

Message in reply to:

ONXX..$42.90 Phase III MISSION trial of Nexavar in Patients with NSCLC Did Not Meet Primary Endpoint. http://yhoo.it/KGJw65

Sheff's Station...All Aboard...Sign Up Here!

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.